The recent success of mRNA vaccines has boosted the prospects for the development of a new class of designer medicines based on mRNA. This Review discusses the multiple design parameters that need to be carefully considered to create highly effective mRNA medicines.
- Mihir Metkar
- Christopher S. Pepin
- Melissa J. Moore